Report from the NASPGN Therapeutics Subcommittee. Report of the activities of the gastrointestinal advisory committee to the FDA.
Kirschner
B S
BS
Wyler Children's Hospital, Chicago, Illinois, USA.
D002648:Child; D003108:Colonic Diseases / Q000188:drug therapy / Q000209:etiology; D003550:Cystic Fibrosis / Q000150:complications; D005762:Gastroenterology; D006801:Humans; D010179:Pancreas / Q000201:enzymology; D010372:Pediatrics; D012955:Societies, Medical; D014481:United States; D014486:United States Food and Drug Administration